Intranasal Insulin for COVID-19-related Smell Loss
Condition(s):Anosmia; Smell Loss; Paraosmia; Hyposmia; COVID-19Last Updated:July 18, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Anosmia; Smell Loss; Paraosmia; Hyposmia; COVID-19Last Updated:July 18, 2022Completed
Condition(s):Hyperglycaemia (Diabetic); Liver TransplantationLast Updated:April 12, 2023Recruiting
Condition(s):Diabetes Mellitus, Type 2Last Updated:December 15, 2023Completed
Condition(s):Type 1 Diabetes; Hyperglycemia, PostprandialLast Updated:October 7, 2022Terminated
Condition(s):Type 1 Diabetes; Insulin TherapyLast Updated:March 31, 2022Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:January 18, 2022Completed
Condition(s):Type 1 DiabetesLast Updated:July 27, 2020Completed
Condition(s):Diabetes Type 2Last Updated:March 20, 2024Not yet recruiting
Condition(s):type1diabetes; Type2 DiabetesLast Updated:November 19, 2021Unknown status
Condition(s):Type 2 Diabetes Treated With InsulinLast Updated:March 15, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.